New Therapeutic Strategies for Brain Edema and Cell Injury, Volume 145, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this volume presenting interesting chapters on the Blood-brain barrier breakdown and brain edema formation in Alzheimer’s disease, Blast brain Injury induced edema formation and therapeutic measures, Brain edema in Parkinson’s disease. Novel therapeutic strategies, Brain edema and blood-brain barrier breakdown in sleep deprivation. Therapeutic potential of cerebrolysin, Differential cell injury induced by NMDA antagonist MK 801 in early age, Anesthetics influence Brain edema in concussive head injury, and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Series Page - p. ii 5. Copyright - p. iv 6. Contributors - p. ix 7. Preface - p. xiii 8. Acknowledgments - p. xxi 9. Chapter One 5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology - p. 1 10. Chapter Two Anesthetics influence concussive head injury induced blood-brain barrier breakdown, brain edema formation, cerebral blood flow, serotonin levels, brain pathology and functional outcome - p. 45 11. Chapter Three Potentiation of spinal cord conduction and neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord injury induced functional outcome, blood-spinal cord barrier breakdown and edema formation - p. 83 12. Chapter Four Leakage of the blood-brain barrier followed by vasogenic edema as the ultimate cause of death induced by acute methamphetamine overdose - p. 119 13. Chapter Five Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders - p. 139 14. Chapter Six Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia - p. 169 15. Chapter Seven New therapeutic approaches to target alpha-synuclein in Parkinson's disease: The role of immunotherapy - p. 191
New Therapeutic Strategies for Brain Edema and Cell Injury, Volume 145, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this volume presenting interesting chapters on the Blood-brain barrier breakdown and brain edema formation in Alzheimer’s disease, Blast brain Injury induced edema formation and therapeutic measures, Brain edema in Parkinson’s disease. Novel therapeutic strategies, Brain edema and blood-brain barrier breakdown in sleep deprivation. Therapeutic potential of cerebrolysin, Differential cell injury induced by NMDA antagonist MK 801 in early age, Anesthetics influence Brain edema in concussive head injury, and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Series Page - p. ii 5. Copyright - p. iv 6. Contributors - p. ix 7. Preface - p. xiii 8. Acknowledgments - p. xxi 9. Chapter One 5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology - p. 1 10. Chapter Two Anesthetics influence concussive head injury induced blood-brain barrier breakdown, brain edema formation, cerebral blood flow, serotonin levels, brain pathology and functional outcome - p. 45 11. Chapter Three Potentiation of spinal cord conduction and neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord injury induced functional outcome, blood-spinal cord barrier breakdown and edema formation - p. 83 12. Chapter Four Leakage of the blood-brain barrier followed by vasogenic edema as the ultimate cause of death induced by acute methamphetamine overdose - p. 119 13. Chapter Five Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders - p. 139 14. Chapter Six Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia - p. 169 15. Chapter Seven New therapeutic approaches to target alpha-synuclein in Parkinson's disease: The role of immunotherapy - p. 191
